(Q38429953)

3 September 2017

title

COX-2-selective NSAIDs and risk of hip or knee replacements: a population-based case-control study (English)

1 reference

3 September 2017

Frank de Vries

2

0 references

author name string

Corinne Klop

1

1 reference

3 September 2017

Arief Lalmohamed

3

1 reference

3 September 2017

Simon C Mastbergen

4

1 reference

3 September 2017

Hubert G M Leufkens

5

1 reference

3 September 2017

Willemijn H Noort-van der Laan

6

1 reference

3 September 2017

Johannes W J Bijlsma

7

1 reference

3 September 2017

Paco M J Welsing

8

1 reference

3 September 2017

language of work or name

English

0 references

publication date

9 October 2012

1 reference

Calcified Tissue International

3 September 2017

published in

1 reference

3 September 2017

volume

91

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

387-394

1 reference

Osteoarthritis: an update with relevance for clinical practice

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Chondroprotective drugs in degenerative joint diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Do NSAIDs affect longitudinal changes in knee cartilage volume and knee cartilage defects in older adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Use of organic nitrates and the risk of hip fracture: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Use of anti-depressants and the risk of fracture of the hip or femur.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Risk of hip/femur fracture after stroke: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Patient-reported outcomes in the Swedish Hip Arthroplasty Register: results of a nationwide prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Channeling bias in the interpretation of drug effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

Use of inhaled corticosteroids and the risk of non-fatal acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9646-X

10.1007/S00223-012-9646-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1050400201

0 references

1 reference